^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BCMA-PD1-CART Cells
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Chinese PLA General Hospital
Drug class:
BCMA-targeted CAR-T immunotherapy, PD1-targeted CAR-T immunotherapy
Related drugs:
Phase 2
Chinese PLA General Hospital
Recruiting
Last update posted :
11/18/2019
Initiation :
07/07/2019
Primary completion :
10/10/2021
Completion :
10/10/2022
PD-1
|
cyclophosphamide • BCMA-PD1-CART Cells
Share
